Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
clinical decrease » clinical disease (Expand Search), clinical case (Expand Search), linear decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
clinical decrease » clinical disease (Expand Search), clinical case (Expand Search), linear decrease (Expand Search)
-
961
The RehaGait® system.
Published 2025“…</p><p>Trial registration</p><p>ClinicalTrials.gov <a href="https://clinicaltrials.gov/ct2/show/NCT04795089" target="_blank">NCT04795089</a></p></div>…”
-
962
Flow chart of included patients and dropouts.
Published 2025“…</p><p>Trial registration</p><p>ClinicalTrials.gov <a href="https://clinicaltrials.gov/ct2/show/NCT04795089" target="_blank">NCT04795089</a></p></div>…”
-
963
Dataset of the analyzed data.
Published 2025“…</p><p>Trial registration</p><p>ClinicalTrials.gov <a href="https://clinicaltrials.gov/ct2/show/NCT04795089" target="_blank">NCT04795089</a></p></div>…”
-
964
Data Sheet 1_Dual variants of uncertain significance in a case of hyper-IgM syndrome: implications for diagnosis and management.pdf
Published 2025“…Background<p>Hyper-IgM syndrome (HIGM) is a genetic immunodeficiency characterized by elevated to normal IgM levels and decreased IgG, IgA, and IgE. The overlapping clinical presentations of different gene mutations complicate diagnosis and management.…”
-
965
Data Sheet 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx
Published 2025“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”
-
966
Data Sheet 2_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx
Published 2025“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”
-
967
Data Sheet 3_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx
Published 2025“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”
-
968
-
969
-
970
-
971
-
972
Univariate analysis of hospitalized patients.
Published 2025“…RPR was a significant prognostic indicator. Elevated RPR correlated with coagulation dysfunction (increased PT/INR, decreased fibrinogen) and higher mortality risk. …”
-
973
Univariate analysis of ICU patients.
Published 2025“…RPR was a significant prognostic indicator. Elevated RPR correlated with coagulation dysfunction (increased PT/INR, decreased fibrinogen) and higher mortality risk. …”
-
974
International Classification of Diseases Codes.
Published 2025“…RPR was a significant prognostic indicator. Elevated RPR correlated with coagulation dysfunction (increased PT/INR, decreased fibrinogen) and higher mortality risk. …”
-
975
S1 File -
Published 2025“…When compared to DistilBERT (66 million parameters) and ClinicalBERT (110 million parameters), LastBERT demonstrated comparable performance, with DistilBERT slightly outperforming it at 87%, and ClinicalBERT achieving 86% across the same metrics. …”
-
976
Confusion matrix for LastBERT model.
Published 2025“…When compared to DistilBERT (66 million parameters) and ClinicalBERT (110 million parameters), LastBERT demonstrated comparable performance, with DistilBERT slightly outperforming it at 87%, and ClinicalBERT achieving 86% across the same metrics. …”
-
977
Student model architecture.
Published 2025“…When compared to DistilBERT (66 million parameters) and ClinicalBERT (110 million parameters), LastBERT demonstrated comparable performance, with DistilBERT slightly outperforming it at 87%, and ClinicalBERT achieving 86% across the same metrics. …”
-
978
Configuration of the LastBERT model.
Published 2025“…When compared to DistilBERT (66 million parameters) and ClinicalBERT (110 million parameters), LastBERT demonstrated comparable performance, with DistilBERT slightly outperforming it at 87%, and ClinicalBERT achieving 86% across the same metrics. …”
-
979
Confusion matrix for DistilBERT model.
Published 2025“…When compared to DistilBERT (66 million parameters) and ClinicalBERT (110 million parameters), LastBERT demonstrated comparable performance, with DistilBERT slightly outperforming it at 87%, and ClinicalBERT achieving 86% across the same metrics. …”
-
980
ROC curve for LastBERT model.
Published 2025“…When compared to DistilBERT (66 million parameters) and ClinicalBERT (110 million parameters), LastBERT demonstrated comparable performance, with DistilBERT slightly outperforming it at 87%, and ClinicalBERT achieving 86% across the same metrics. …”